SELOMIDA Nerfs pdr 30 sach 7.5 g

7680653570018 CH-65357 20.01.4.
SELOMIDA Nerfs pdr 30 sach 7.5 g
SELOMIDA Nerfs pdr 30 sach 7.5 g
SELOMIDA Nerfs pdr 30 sach 7.5 g
1 / 3
google

Details

Product number
6535701
CPT
-
Packaging group
30 x 7.5
Unit
g
Composition
calcii hydrogenophosphas dihydricus D6, kalii dihydrogenophosphas D6, magnesii hydrogenophosphas trihydricus D6, acidum silicicum D12, calcii carbonas D12 ana partes ad pulverem pro charta 7.5 g.

Articles (1)

Selomida Nerven, Pulver zum Einnehmen
Pulver
30 x 7.5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/04/2024
Patient information leaflet
Français
15/04/2024
Patient information leaflet
Italien
15/04/2024

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)

Authorization holder

Schwabe Pharma AG

6403 Küssnacht am Rigi

Authorization information

Swissmedic authorization number
65357
Drug name
Selomida Nerven, Pulver zum Einnehmen
Galenic form
PULOR
Authorization status
Z
Dispensation category
D
First authorization
28/09/2016
Authorization expiration date
31/12/9999
IT number
20.01.4.
Domain
Human medicine
Field of application
Gemäss dem biochemischen Therapieprinzip nach Dr. Schüssler zur Unterstützung bei nervösen Spannungs- und Erschöpfungszuständen nach erhöhter Belastung oder Überanstrengung.

Packaging details

Description (FR)
SELOMIDA Nerfs pdr 30 sach 7.5 g
Description (DE)
SELOMIDA Nerven Plv 30 Btl 7.5 g
Market launch
28/09/2016
Narcotic (BTM)
No

Other packaging sizes